Home › Funds › Jones Hill Capital LP › TRVI

Jones Hill Capital LP position in TRVI

TREVI THERAPEUTICS INC · Health Care

Jones Hill Capital LP reported holding 1,447,156 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$20.7M, representing 3.52% of its reported portfolio and ranking #11 among its reported holdings. Jones Hill Capital LP has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.45M sh
Reported value held$20.72M
Portfolio Weight3.52%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Jones Hill Capital LP's TRVI position evolved

Jones Hill Capital LP first disclosed a stake in TRVI in Q1 2026 at 370,175 shares (US$4.4M). The position peaked in Q2 2026 at 1,339,212 shares, worth US$25.0M. Across 3 filings, Jones Hill Capital LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,447,156 shares valued at US$20.7M — an increase of 107,944 shares quarter over quarter.. Notable position changes include a 262% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 370.18K $4.42M New
Q2 2026 1.34M $24.98M Add
Q3 2026 1.45M $20.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$60.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has Jones Hill Capital LP held TRVI?

Jones Hill Capital LP has disclosed TRVI holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Jones Hill Capital LP's current position in TRVI?

As of Q3 2026, Jones Hill Capital LP holds 1.45M shares of TRVI (TREVI THERAPEUTICS INC), valued at $20.72M, representing 3.52% of its reported portfolio and ranking #11.

Has Jones Hill Capital LP been buying or selling TRVI?

In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in TRVI. The position peaked in Q2 2026 at 1.34M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.